(Q38000079)

26 August 2017

title

The role of FDG PET-CT in the therapeutic evaluation for HNSCC patients (English)

1 reference

head and neck squamous cell carcinoma

26 August 2017

main subject

1 reference

Joji Kawabe

1

1 reference

26 August 2017

Shigeaki Higashiyama

2

1 reference

26 August 2017

Atsushi Yoshida

3

1 reference

26 August 2017

Kohei Kotani

4

1 reference

26 August 2017

Susumu Shiomi

5

1 reference

26 August 2017

publication date

5 April 2012

1 reference

Japanese journal of radiology

26 August 2017

published in

1 reference

26 August 2017

volume

30

1 reference

26 August 2017

issue

6

1 reference

26 August 2017

page(s)

463-470

1 reference

High-dose chemotherapy in germ cell tumours: a large single centre experience.

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0076-5

Additional value of integrated PET/CT over PET alone in the initial staging and follow up of head and neck malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0076-5

Indications for PET/CT in the head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0076-5

The role of positron emission tomography and computed tomography fusion in the management of early-stage and advanced-stage primary head and neck squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0076-5

FDG-PET/CT imaging for staging and radiotherapy treatment planning of head and neck carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0076-5

Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0076-5

Role of functional imaging in head and neck squamous cell carcinoma: fluorodeoxyglucose positron emission tomography and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0076-5

Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0076-5

Innovations in radiotherapy planning of head and neck cancers: role of PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0076-5

Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0076-5

Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0076-5

18F-FDG PET/CT-based gross tumor volume definition for radiotherapy in head and neck cancer: a correlation study between suitable uptake value threshold and tumor parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0076-5

The role of post-radiation therapy FDG PET in prediction of necessity for post-radiation therapy neck dissection in locally advanced head-and-neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0076-5

A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0076-5

FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0076-5

Current use of 18F-fluorodeoxyglucose positron emission tomography and combined positron emission tomography and computed tomography in squamous cell carcinoma of the head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0076-5

PET-CT vs contrast-enhanced CT: what is the role for each after chemoradiation for advanced oropharyngeal cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0076-5

PET monitoring of therapy response in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0076-5

Positron-emission tomography for surveillance of head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0076-5

Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for Locoregional advanced head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0076-5

The role of positron emission tomography scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0076-5

Deferring planned neck dissection following chemoradiation for stage IV head and neck cancer: the utility of PET-CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0076-5

Diagnostic performance of response assessment FDG-PET/CT in patients with head and neck squamous cell carcinoma treated with high-precision definitive (chemo)radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0076-5

Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation

21 January 2018

1 reference

12 December 2020

Positron emission tomography with fluorodeoxyglucose for suspected head and neck tumor recurrence in the symptomatic patient

1 reference

12 December 2020

Change induced by radiation therapy in FDG uptake in normal and malignant structures of the head and neck: quantitation with PET

1 reference

12 December 2020

The use of combined PET/CT for localizing recurrent head and neck cancer: the Pittsburgh experience

1 reference

12 December 2020

FDG PET in head and neck cancer

1 reference

12 December 2020

Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.

1 reference

12 December 2020

Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer

1 reference

12 December 2020

The applications of PET in clinical oncology

1 reference

12 December 2020

Combined PET-CT in the head and neck: part 1. Physiologic, altered physiologic, and artifactual FDG uptake

1 reference

12 December 2020

Laryngeal or hypopharyngeal squamous cell carcinoma: can follow-up CT after definitive radiation therapy be used to detect local failure earlier than clinical examination alone?

1 reference

12 December 2020

Experience in qualitative and quantitative FDG PET in follow-up of patients with suspected recurrence from head and neck cancer

1 reference

12 December 2020

Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma.

1 reference

12 December 2020

Head and neck malignancy: is PET/CT more accurate than PET or CT alone?

1 reference

12 December 2020

Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers

1 reference

12 December 2020

10.1007/S11604-012-0076-5

Identifiers

DOI

1 reference

Dimensions Publication ID

26 August 2017

1027881739

0 references

1 reference